义翘神州 specializes in the production of proteins and antibodies, providing various custom services and solutions for drug development.

义翘神州

Sino Biological, Inc. | 21,568 followers on LinkedIn. Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research. Sino Biological has amassed a global presence with its headquarters in Beijing, China, and subsidiaries in Suzhou and Taizhou, China, the United States, Europe, and Japan.

Laboratory Manager, Center for Bioprocessing, Sino Biological US Inc.

Karen Moberg

Director of BD @ Sino Biological

Dario P.

Technical Specialist/Business Development UK at Sino Biological

Ali Abdul-Gader

e-marketing at Sino Biological Inc

Jack Lu

Sino Biological, Inc.

Join us on December 4th at 2PM CT / 3PM ET to explore the future of mRNA vaccine characterization! Dr. Randy Lacey , Field Application Scientist at InDevR, Inc. , will showcase how the VaxArray platform simplifies complex analytical processes with cutting-edge tools like the 5’ CapQ Assay for mRNA integrity assessment and the OmniFlu HA/NA Assay for multiplexed influenza antigen analysis, highlighting how Sino Biological's reagents play a critical role in advancing these assays. ➡️ Register now to secure your spot: https://ow.ly/gAQl50UbheB #mRNAVaccines #VaccineDevelopment #Biotech #Webinar

Day 2 let's go! PROTEIN SCIENCES IN DRUG DISCOVERY 2024 by the wonderful ELRIG UK and The Protein Society here in Hinxton Hall Conference Centre at the Wellcome Genome Campus . Wanchen and I are of course repping Sino Biological, Inc. and yesterday we had some fantastic talks from the likes of Sygnature Discovery , GSK and AstraZeneca . Looking forward to what is in store today!

Robert Naughton

EGFR plays a critical role in cancer cell growth, making it a major focus for innovative treatments. From monoclonal antibodies to small-molecule inhibitors, therapies have come a long way—but resistance remains a significant challenge. Explore the latest advances, challenges, and potential strategies for overcoming resistance in EGFR-targeted therapies in this week's newsletter. #Biotech #Cancer #CancerResearch

🎉 New Year Promotion 🎉 Australian researchers—kick off the new year with these special offers from Sino Biological: 1️⃣ Order Gifts: Place an order now to receive a customized gift from us! 2️⃣ Free Cytokine Samples: Get high-quality cytokine samples delivered directly to your lab at no cost. 3️⃣ New Lab Discount: Starting up a new lab? Enjoy 50% off all proteins and antibodies! 📍 Offer available for Australian customers only. Learn more and take advantage of these limited-time offers here: https://ow.ly/fH4750U9cm2 #NewYearPromotion #LifeSciences #Biotech

✨ A big thank you to our distributor Prodotti Gianni for visiting our European office and for the wonderful discussions! It was a pleasure hosting you, and we’re excited about the opportunities for further collaboration. Special thanks to Roberta Bianchi and Caterina Cremonesi for the wine — we couldn’t resist, it’s already gone! 🥂🍾 Here’s to a successful partnership and more shared celebrations in the future! #Partnership #Collaboration #ThankYou #Cheers #Teamwork

This weekend our team was at Society for Immunotherapy of Cancer (SITC) 2024 in Houston, TX! Mr. Snail and Coco had a great time exploring the convention center and meeting new folks at our booth! 🐌 🐦⬛ Xue “Mary” Yu , Tong Huo , Lauren Mondshine , Jacob Baerenstecher , Amanda Garrett , Sylvia Xie , Edgar O. Correa-Colón, Ph.D. #SITC2024 #Cancer #Immunotherapy #HTX

Cytoplasmic tyrosine kinases (CTKs) are critical regulators of cellular processes such as growth, differentiation, and survival. Clinically relevant CTKs, including JAK, ABL, SYK, and SRC, are linked to autoimmune diseases and cancers, making them important drug targets. Read more about CTKs in this week's newsletter! #Kinases #ChronicIllness #AutoimmuneDisease #Cancer

Thank you to everyone who joined us at the 2024 Houston Nutrition & Obesity Research Symposium on Saturday, November 9! We are incredibly grateful for the insightful talks and for the opportunity to connect with so many dedicated scientists and researchers. Congratulations to the 10 winners of our poster session, and thank you to everyone who participated and presented their work. We look forward to seeing the advancements in your research and connecting with you at future events!

Join Oxford Global and Ritwika Biswas Biswas, Field Application Scientist at Sino Biological, for a webinar to discover the pivotal role of GMP-grade cytokines like IL-2, IL-7, and IL-15 in optimizing cell-based therapies on Tuesday, November 19 at 11AM CT / 12PM ET. Why attend? 💡Gain insights into how GMP-grade cytokines enhance immune cell function and drive effective treatments. 💡Learn strategies to ensure safety and consistency in clinical applications. 💡Understand the regulatory standards surrounding GMP-grade cytokines. 💡Discover how to leverage these cytokines to improve therapeutic outcomes for cancer and autoimmune disorders. Register: https://ow.ly/MHWF50U2FwN #CancerResearch #Biotechnology #CellTherapy #Webinar

At Sino Biological, we're dedicated to advancing cell and gene therapy through high-quality GMP-grade raw materials. Our mission? To empower the future of medicine with safe, scalable solutions that meet the highest international standards 🌐. From rigorous contamination control to consistency across batches, we ensure each product is ready for your most critical applications. 🌍 Learn how our global network and state-of-the-art GMP facilities are supporting cell and gene therapy at every stage. #Biotech #GeneTherapy #CellTherapy

Metric
Company Name	义翘神州
Symbol
MSH ID	COM:SINOBIOLOGICAL:CN
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	CN
Stage	Venture Round
Employee Count
Website	cn.sinobiological.com
LinkedIn	sino-biological-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	158.72K
Web Traffic Growth	0.13
Valuation
Raised Capital	15.76M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SINO

COM:SINOBIOLOGICAL:CN

义翘神州

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue